The Lung Channel

Explore the latest updates, including expert interviews, features and podcasts

The Lung Cancer Channel on VJOncology is supported by Takeda and Novocure. These supporters have no influence over the production of the content.

Latest videos WCLC 2022 Conferences The Lung Cancer Sessions Subtypes Topics Podcasts Features Editorial Board

Welcome to The Lung Channel!

Alongside a world-leading Editorial Board, VJOncology shares the latest updates you need in lung cancer. Speaking directly with the experts at international congresses, The Lung Channel brings you video interviews, podcasts, roundtable discussions, and more.

As well as updates in therapy including the use of immunotherapy and targeted therapies, the Lung Channel covers advances in radiotherapy, surgical approaches, and biomarkers of response.

 

Lung Cancer Videos by Conference

ASCO 2023
BTOG 2023
ESMO 2022
WCLC 2022
BTOG 2022 Summer Meeting
ASCO 2022
3:22
Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation
Young Kwang Chae • 3 Jun 2023
0:38
Advancing targeted therapies for SCLC
Sophie Cousin • 3 Jun 2023
0:50
Efficacy and safety of lurbinectedin in elderly patients with relapsed SCLC
Sophie Cousin • 3 Jun 2023
0:53
The OTHERS study: optimal duration of checkpoint inhibitors in solid tumors
Patrizia Giannatempo • 3 Jun 2023
View All Videos
2:42
The benefits of immunotherapy versus chemotherapy: analyzing the results of the IPSOS trial
Riyaz Shah • 28 Apr 2023
1:47
BTOG 2023 for trainees
Anand Sundaralingham • 28 Apr 2023
1:59
Using real-world data to optimize patient pathways in lung cancer
Apurna Jegannathen • 28 Apr 2023
8:53
The targeted lung health check (TLHC) program in the UK
Robert Rintoul • 28 Apr 2023
View All Videos
2:02
Biological mechanisms of lung cancer initiation and progression
Charles Swanton • 12 Sep 2022
1:28
Highlights from ESMO 2022 in melanoma
Omid Hamid • 12 Sep 2022
2:43
Phase I dose escalation of IMC-F106C, a PRAME × CD3 ImmTAC bispecific protein in solid tumors
Omid Hamid • 12 Sep 2022
2:01
Unanswered questions on immunotherapy for lung cancer
Solange Peters • 11 Sep 2022
View All Videos
1:10
Pro-inflammatory tumor profile predicts PCR in NSCLC to neoadjuvant chemoimmunotherapy
Marta Casarrubios • 8 Aug 2022
2:53
HUDSON: Durvalumab combination therapies to overcome PD-L1 blockade resistance in advanced NSCLC
Benjamin Besse • 7 Aug 2022
1:26
The challenge of treatment resistance in patients with advanced EGFR-mutated NSCLC
Qing Zhou • 8 Aug 2022
3:30
Comparing progression-free survival in the ASTRIS and SANOVO trials
Qing Zhou • 8 Aug 2022
View All Videos
4:04
The centralization of molecular testing
John Gosney • 8 Jul 2022
1:29
Updates in lung cancer management from the BTOG 2022 Summer Meeting
Riyaz Shah • 8 Jul 2022
1:27
Which subtypes of patients with mesothelioma are most likely to benefit from immunotherapy?
Riyaz Shah • 8 Jul 2022
1:05
Improving immunotherapy outcomes in mesothelioma
Riyaz Shah • 8 Jul 2022
View All Videos
1:42
Next-generation ALK inhibitors: treatment sequencing and resistance
Alessandra Bearz • 6 Jun 2022
1:11
Unanswered questions regarding the use of IO in NSCLC
Jarushka Naidoo • 5 Jun 2022
1:28
Highlights in NSCLC from ASCO 2022
Jarushka Naidoo • 5 Jun 2022
0:48
Chemotherapy-free immunotherapy-based treatment approaches for NSCLC
Jarushka Naidoo • 5 Jun 2022
View All Videos

Videos by Topic

Immuno-Oncology
Early Diagnosis
Trial Updates
Screening
Molecular Profiling
6:49
EVOKE-02: sacituzumab govitecan and pembrolizumab in first-line NSCLC
Byoung Chul Cho • 19 Sep 2023
1:08
The future of I-SABR in lung cancer
Joe Chang • 31 Aug 2023
1:51
Outcomes of I-SABR in lung cancer
Joe Chang • 31 Aug 2023
1:24
ADCs in lung cancer treatment
Xiuning Le • 1 Sep 2023
View All Videos
8:53
The targeted lung health check (TLHC) program in the UK
Robert Rintoul • 28 Apr 2023
1:24
Early diagnosis of lung cancer: AI, lung nodules, liquid biopsies
Richard Lee • 28 Apr 2023
0:47
Key radiology highlights at BTOG 2023
Kevin Blyth • 27 Apr 2023
0:47
Key radiology highlights at BTOG 2023
Kevin Blyth • 27 Apr 2023
View All Videos
6:49
EVOKE-02: sacituzumab govitecan and pembrolizumab in first-line NSCLC
Byoung Chul Cho • 19 Sep 2023
3:53
Poziotinib in pretretaed, HER2 exon 20 insertion NSCLC
Xiuning Le • 1 Sep 2023
6:13
VISION: tepotinib in MET exon 14 skipping NSCLC
Xiuning Le • 1 Sep 2023
3:45
Outcomes of secondary analysis for RTOG 0617
Stephen Chun • 6 Sep 2023
View All Videos
0:50
The challenges of implementing lung cancer screening in Africa
Lauren Pretorius • 31 Aug 2023
0:50
Increasing lung cancer screening rates in Africa
Lauren Pretorius • 31 Aug 2023
3:36
Facilitating the decision-making process for patients during lung cancer screening
David Baldwin • 29 Aug 2023
0:53
Accommodating unmet needs in geriatric patients with lung cancer
Shalini Vinod • 29 Aug 2023
View All Videos
4:51
Prognostic molecular and genetic factors for NSCLC
Akif Turna • 29 Aug 2023
0:38
Advancing targeted therapies for SCLC
Sophie Cousin • 3 Jun 2023
3:23
Antibody-drug conjugates in the treatment of solid tumors
Kohei Shitara • 3 Jun 2023
1:17
Advancements in targeted therapies for oncogene-driven resectable NSCLC
Samuel Rosner • 3 Jun 2023
View All Videos

The Lung Cancer Channel on VJOncology is supported by Takeda and Novocure.

These supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Lung Channel, please contact us .

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals